Month: January 2022

The full treatment of Molulife (brand name) is expected to cost ₹1,400, RC Juneja, chairman of Mankind Pharma, told ET.…

Over a dozen companies, including Hetero, Sun Pharma, Natco and Dr Reddy’s are in the process of rolling out the…

On October 25, 2021, in response to Bharat Biotech International Limited’s letter, the Central Drugs Standard Control Organisation (CDSCO) approved…

The government had announced the initiation of vaccination for children in the age group of 15-18 years amidst a rapid…

The registration in 15-18 year age group started on CoWin on Saturday. Other platforms including Aarogya Setu will offer the…

Some people will require hospitalisation and oxygen, but even they are “unlikely to require ventilators”, he said., Some people will…

The Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moderate…

Stressing on the need to ensure smooth implementation of new vaccination guidelines, the health ministry said that the states have…

India’s first dose coverage crossed 90 percent a few days ago which takes it ahead of USA, which has covered…

In view of the rising trajectory of COVID cases owing to the highly transmissible Omicron variant which can overwhelm the…